Walgreen Glycerin Adult

Description

Glycerin suppositories are formulated as a clear, colorless to pale yellow, viscous liquid. Each suppository contains 2.0 g of glycerin as the active ingredient. The formulation includes several inactive ingredients: purified water, sodium bicarbonate, sorbitol, propylene glycol, gelatin, sodium lauryl sulfate, citric acid, potassium sorbate, methylparaben, propylparaben, and both natural and artificial flavors.

Uses and Indications

This drug is indicated for the relief of occasional constipation (irregularity). It generally produces a bowel movement within 15 minutes to 1 hour after administration.

Dosage and Administration

For adults and children aged 6 years and older, the recommended dosage is one suppository per day, or as directed by a healthcare professional.

For children aged 2 to under 6 years, it is advised to use Walgreens Infants & Children suppositories specifically formulated for this age group.

In the case of children under 2 years of age, consultation with a healthcare provider is recommended prior to administration.

Contraindications

Use of laxative products is contraindicated for periods exceeding one week unless directed by a healthcare professional. Prolonged use may lead to dependency or other adverse effects.

Warnings and Precautions

For rectal use only. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Laxative products should not be utilized for a duration exceeding one week unless specifically directed by a healthcare professional. Prolonged use may lead to adverse effects and should be closely monitored.

Patients are advised to discontinue use and consult a physician if rectal bleeding occurs or if there is a failure to have a bowel movement following the use of a laxative. These symptoms may indicate a serious underlying condition that requires medical evaluation.

While using this product, individuals may experience rectal discomfort or a burning sensation. Such reactions should be monitored, and if they persist or worsen, medical advice should be sought.

Prior to use, it is essential for patients to consult a healthcare provider if they have any of the following conditions: abdominal pain, nausea, vomiting, or if they have observed a sudden change in bowel habits lasting more than two weeks. These factors may necessitate further investigation and could influence the safe use of the product.

Side Effects

Patients using this product should be aware that it is intended for rectal use only. It is important to monitor for any serious adverse reactions. Patients are advised to discontinue use and consult a healthcare professional if they experience rectal bleeding or if they do not have a bowel movement after using the laxative, as these symptoms may indicate a serious underlying condition.

Additionally, patients should seek medical advice prior to use if they have a history of abdominal pain, nausea, vomiting, or if they notice a sudden change in bowel habits that persists for more than two weeks. These conditions may warrant further evaluation by a healthcare provider to ensure safety and appropriate management.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Walgreen Glycerin Adult (glycerin suppository). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 years and older may be administered 1 suppository per day or as directed by a healthcare professional. For children aged 2 to under 6 years, Walgreens Infants & Children suppositories are recommended. It is advised that parents or caregivers consult a doctor before using this medication in children under 2 years of age.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment may require dosage adjustments due to reduced renal function. It is essential to monitor renal function tests regularly in individuals with known kidney problems to ensure safe and effective use of the medication. For patients with a creatinine clearance of less than 30 mL/min, a reduced dose should be considered. Additionally, special monitoring is necessary for patients with severe renal impairment to mitigate potential risks associated with treatment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from excessive dosing. Symptoms of overdosage can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose effectively. Additionally, healthcare professionals should refer to local protocols and guidelines for the management of overdose situations, as these may provide specific recommendations based on the substance involved.

Overall, vigilance and prompt intervention are critical in managing any suspected overdosage effectively.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. In cases of rectal bleeding or failure to have a bowel movement following the use of a laxative, it is important to discontinue use and seek medical advice, as these symptoms may indicate a serious underlying condition.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that laxative products should not be used for longer than one week unless directed by a healthcare professional.

Patients should be instructed to discontinue use and consult a doctor if they experience rectal bleeding or do not have a bowel movement after using the laxative, as these symptoms may indicate a serious condition. Additionally, patients may experience rectal discomfort or a burning sensation while using the product, and this should be communicated to them.

Healthcare providers should encourage patients to consult with a doctor prior to use if they have any of the following conditions: abdominal pain, nausea, vomiting, or if they have noticed a sudden change in bowel habits that persists for more than two weeks. This precaution is essential to ensure the safe and effective use of the product.

Storage and Handling

The product is supplied in a tightly closed container to maintain integrity and prevent contamination. It is essential to store the product in a cool, dry place, avoiding exposure to excessive heat to ensure optimal stability and efficacy. Proper handling should be observed to maintain the quality of the product throughout its shelf life.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Walgreen Glycerin Adult, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)